Literature DB >> 25092600

Familial clustering of ESRD in the Norwegian population.

Rannveig Skrunes1, Einar Svarstad2, Anna Varberg Reisæter3, Bjørn Egil Vikse4.   

Abstract

BACKGROUND AND OBJECTIVES: Studies and clinical experience suggest that kidney disease clusters in families, but few population-based studies have been performed. This study investigates risks and causes of ESRD in Norwegians with and without a first-degree relative with ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: On the basis of data from the Norwegian Population Registry, first-degree relatives for most Norwegians were identified. All Norwegians with ESRD (defined as chronic RRT) since 1980 have been registered in the Norwegian Renal Registry. All Norwegians born in Norway who were alive in 1980 and had at least one registered relative were included. For this study, data on ESRD were available through 2009, and individuals without ESRD were censored at December 31, 2009. Data were analyzed in a cohort design, with ESRD in a first-degree relative of the included person as the main explanatory variable. Risks of ESRD and different causes of ESRD were analyzed using Cox regression statistics.
RESULTS: In total, 5,119,134 individuals were included, of whom 8203 individuals developed ESRD during follow-up and 27,046 individuals had a first-degree relative with ESRD. Compared with individuals without a first-degree relative with ESRD, individuals with a first-degree relative with ESRD had a relative risk of ESRD of 7.2 (95% confidence interval, 6.5 to 8.1). Similar analyses showed that relative risk of ESRD caused by nonhereditary causes was 3.7 (95% confidence interval, 3.1 to 4.4), relative risk of ESRD caused by glomerular disease was 5.2 (95% confidence interval, 4.1 to 6.6), relative risk of ESRD caused by interstitial disease was 4.7 (95% confidence interval, 3.1 to 7.3), relative risk of ESRD caused by diabetic nephropathy was 2.6 (95% confidence interval, 1.6 to 4.1), and relative risk of ESRD caused by hypertensive nephrosclerosis was 2.6 (95% confidence interval, 1.6 to 4.1). Relative risk of nonhereditary parenchymal renal disease was 3.8 (95% confidence interval, 3.1 to 4.7).
CONCLUSIONS: As expected, ESRD clusters in families. Interestingly, ESRD without known hereditary cause also clusters in families.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  ESRD; family history; nephrology

Mesh:

Year:  2014        PMID: 25092600      PMCID: PMC4186510          DOI: 10.2215/CJN.01680214

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

Review 1.  IgA nephropathy.

Authors:  Jonathan Barratt; John Feehally
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

2.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

3.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

4.  Population-based screening for family history of end-stage renal disease among incident dialysis patients.

Authors:  Barry I Freedman; Nataliya V Volkova; Scott G Satko; Jenna Krisher; Claudine Jurkovitz; J Michael Soucie; William M McClellan
Journal:  Am J Nephrol       Date:  2005-09-21       Impact factor: 3.754

5.  Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

Authors:  P C van Dijk; K J Jager; F de Charro; F Collart; R Cornet; F W Dekker; C Grönhagen-Riska; R Kramar; T Leivestad; K Simpson; J D Briggs
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

6.  Family history of end-stage renal disease among incident dialysis patients.

Authors:  B I Freedman; J M Soucie; W M McClellan
Journal:  J Am Soc Nephrol       Date:  1997-12       Impact factor: 10.121

7.  Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.

Authors:  D F O'Dea; S W Murphy; D Hefferton; P S Parfrey
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

8.  Familial factors determine the development of diabetic nephropathy in patients with IDDM.

Authors:  M Quinn; M C Angelico; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

Review 9.  Genetic factors in diabetic nephropathy.

Authors:  Barry I Freedman; Meredith Bostrom; Pirouz Daeihagh; Donald W Bowden
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 8.237

10.  Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.

Authors:  William McClellan; Rebecca Speckman; Leslie McClure; Virginia Howard; Ruth C Campbell; Mary Cushman; Paul Audhya; George Howard; David G Warnock
Journal:  J Am Soc Nephrol       Date:  2007-03-07       Impact factor: 10.121

View more
  35 in total

1.  Renal Function Profile in White Kidney Donors: The First 4 Decades.

Authors:  Hassan N Ibrahim; Robert N Foley; Scott A Reule; Richard Spong; Aleksandra Kukla; Naim Issa; Danielle M Berglund; Gretchen K Sieger; Arthur J Matas
Journal:  J Am Soc Nephrol       Date:  2016-02-17       Impact factor: 10.121

2.  Personalized medicine in chronic kidney disease by detection of monogenic mutations.

Authors:  Dervla M Connaughton; Friedhelm Hildebrandt
Journal:  Nephrol Dial Transplant       Date:  2020-03-01       Impact factor: 5.992

3.  Race, Relationship and Renal Diagnoses After Living Kidney Donation.

Authors:  Krista L Lentine; Mark A Schnitzler; Amit X Garg; Huiling Xiao; David Axelrod; Janet E Tuttle-Newhall; Daniel C Brennan; Dorry L Segev
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

4.  Risk factors: familial aggregation of ESRD in Europeans-is it in the genes?

Authors:  Barry I Freedman; Todd W Robinson
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

Review 5.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

6.  Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study.

Authors:  Sneh Lata; Maddalena Marasa; Yifu Li; David A Fasel; Emily Groopman; Vaidehi Jobanputra; Hila Rasouly; Adele Mitrotti; Rik Westland; Miguel Verbitsky; Jordan Nestor; Lindsey M Slater; Vivette D'Agati; Marcin Zaniew; Anna Materna-Kiryluk; Francesca Lugani; Gianluca Caridi; Luca Rampoldi; Aditya Mattoo; Chad A Newton; Maya K Rao; Jai Radhakrishnan; Wooin Ahn; Pietro A Canetta; Andrew S Bomback; Gerald B Appel; Corinne Antignac; Glen S Markowitz; Christine K Garcia; Krzysztof Kiryluk; Simone Sanna-Cherchi; Ali G Gharavi
Journal:  Ann Intern Med       Date:  2017-12-05       Impact factor: 25.391

Review 7.  Genomic medicine for kidney disease.

Authors:  Emily E Groopman; Hila Milo Rasouly; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2018-01-08       Impact factor: 28.314

8.  Monogenic causes of chronic kidney disease in adults.

Authors:  Dervla M Connaughton; Claire Kennedy; Shirlee Shril; Nina Mann; Susan L Murray; Patrick A Williams; Eoin Conlon; Makiko Nakayama; Amelie T van der Ven; Hadas Ityel; Franziska Kause; Caroline M Kolvenbach; Rufeng Dai; Asaf Vivante; Daniela A Braun; Ronen Schneider; Thomas M Kitzler; Brona Moloney; Conor P Moran; John S Smyth; Alan Kennedy; Katherine Benson; Caragh Stapleton; Mark Denton; Colm Magee; Conall M O'Seaghdha; William D Plant; Matthew D Griffin; Atif Awan; Clodagh Sweeney; Shrikant M Mane; Richard P Lifton; Brenda Griffin; Sean Leavey; Liam Casserly; Declan G de Freitas; John Holian; Anthony Dorman; Brendan Doyle; Peter J Lavin; Mark A Little; Peter J Conlon; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2019-02-14       Impact factor: 10.612

9.  A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.

Authors:  Arthur J Matas; Rebecca E Hays; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-01       Impact factor: 8.237

10.  Risk of kidney disease after living kidney donation.

Authors:  Arthur J Matas; Andrew D Rule
Journal:  Nat Rev Nephrol       Date:  2021-02-12       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.